tradingkey.logo
搜索

Standard BioTools Inc

LAB
添加自选
0.868USD
-0.029-3.27%
收盘 07-31 16:00美东报价延迟15分钟
339.79M总市值
4.34市盈率 TTM

关于 Standard BioTools Inc 公司

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Standard BioTools Inc简介

公司代码LAB
公司名称Standard BioTools Inc
上市日期Feb 10, 2011
CEOEgholm (Michael)
员工数量818
证券类型Ordinary Share
年结日Feb 10
公司地址2 Tower Place
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94080
电话16502666000
网址https://www.standardbio.com/
公司代码LAB
上市日期Feb 10, 2011
CEOEgholm (Michael)

Standard BioTools Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
317.28K
+61.05%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
757.80K
+65.98%
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
317.28K
+61.05%
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

常见问题

Standard BioTools Inc的前五大股东是谁?

Standard BioTools Inc 的前五大股东如下:Mr. Sean Mackay

有多少机构持有Standard BioTools Inc(LAB)的股份?

截至2026Q1,共有342家机构持有Standard BioTools Inc的股份,合计持有的股份价值约为317.36M,占公司总股份的81.30%。与2025Q4相比,机构持股有所增加,增幅为773508.00。

哪个业务部门对Standard BioTools Inc的收入贡献最大?

在2026Q1,Consumables业务部门对Standard BioTools Inc的收入贡献最大,创收36.25M,占总收入的42.48%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有